フロリダ州における間質性肺疾患の臨床試験
フロリダ州内の拠点で、間質性肺疾患に関する25件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Clinical Research Specialists LLC - Kissimmee, Kissimmee
- Lakeland Regional Medical Center - Lakeland, Lakeland
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Clinical Research Specialists LLC - Kissimmee, Kissimmee
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/30更新 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA017, Gainesville
- USA006, Naples
- USA026, St. Petersburg
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- New Access Research and Medical Services, Miami
- Eunix Clinical Research, Orlando
- 他1件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/29更新 · NCT05798923A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
- Meris Clinical Research-Brandon-69466, Brandon
- Miami VA Healthcare System, Miami
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT06806592A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Kissimmee
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/11更新 · NCT07816185A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Jacksonville
- GSK Investigational Site, Miami
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05878717A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Gainesville
- GSK Investigational Site, Naples
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06572384A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Cleveland Clinic Florida, Weston
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- AdventHealth Orlando, Orlando
被験者募集中
18歳以上 · 全性別 · 2026/09/02更新 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kissimmee
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/02更新 · NCT07333183A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Tampa General Hospital, Tampa
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/09/02更新 · NCT07285655DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Florida, Gainesville
- NCH Research Institute, Naples
- Advent Health Medical Group Advanced Lung Disease, Orlando
- 他3件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/26更新 · NCT06388421Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
- University of Miami Hospital and Clinics, Miami
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT07486869RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Florida, Jacksonville
被験者募集中第2/3相
18歳〜75歳 · 全性別 · 2026/08/17更新 · NCT06328777An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA006, Naples
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/13更新 · NCT07234032Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Florida, Gainesville
- University of South Florida, Tampa
被験者募集中観察研究
21歳以上 · 全性別 · 2026/08/12更新 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Mayo Clinic of Florida, Jacksonville
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/10更新 · NCT07175038Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- University of South Florida, Tampa
被験者募集中第2相
4歳以上 · 全性別 · 2026/07/22更新 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Ascension Medical Group St. Vincent's Lung Institute, Jacksonville
- Mayo Clinic, Jacksonville
- TGH/USF Center for Advanced Lung Disease and Lung Transplant, Tampa
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Advent Health, Orlando
- Tampa General Hospital Center of Research Excellence, Tampa
被験者募集中観察研究
18歳〜80歳 · 全性別 · 2026/06/26更新 · NCT06129240Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
- Mayo Clinic in Florida, Jacksonville
被験者募集中
18歳以上 · 全性別 · 2026/03/20更新 · NCT06751069Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
- Maule Stem Cell Research Institute, Venice
被験者募集中第1相
18歳以上 · 全性別 · 2026/01/29更新 · NCT07372989Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Florida Lung Asthma and Sleep Specialist, Celebration
- Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
被験者募集中第2相
40歳以上 · 全性別 · 2025/11/12更新 · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Miami
被験者募集中第2相
18歳以上 · 全性別 · 2025/05/07更新 · NCT05892614ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。